Checked May 26 2026
Perceptic
Perceptic sells an AI data-integration layer to big pharma R&D teams that connects proprietary, public, and purchased datasets across the full drug-development lifecycle—from asset scouting through clinical trial design.
Source mix4 reported3 company1 data vendor1 unclassified
Evidence notes
Who uses it: Big pharma and top-tier biotech R&D organizations; named customer is CSL (Australian biotech); Accel's lead investor cited the pitch as following 'the drug' across departmental silos rather than serving a single function.[1]Reported
Public signals: Perceptic emerges from stealth with $12M seed round led by Accel[2]+1Reported
Financing: Total raised is $12,000,000.[1]
Source ledger
- [1]Exclusive: Perceptic, a startup automating drug discovery end-to-end for Big Pharma, emerges from stealth with $12 million in seed funding – DNYUZ
- [2]Exclusive: Ex-Palantir execs raise $12 million for AI drug discovery startup Perceptic | Fortune
- [3]Perceptive eClinical and Kayentis partner to tackle increasing digital system complexity in global clinical trials - Perceptive | Science-Led Clinical Imaging, RTSM & Adjudication
- [4]Perceptive Discovery Announces Strategic Partnership with MH3D and Launch of α-Sight to Advance Alpha Radiopharmaceutical Imaging